31 results
8-K
EX-99.1
GTHX
G1 Therapeutics Inc
1 May 24
Results of Operations and Financial Condition
6:38am
is to provide innovative therapeutic advances for people living with cancer. For additional information, please visit www.g1therapeutics.com
PRE 14A
GTHX
G1 Therapeutics Inc
12 Apr 24
Preliminary proxy
4:12pm
in areas of high unmet need including triple-negative breast cancer and extensive stage small cell lung cancer. G1’s goal is to provide innovative … and vaccine manufacturing. Starting in 2023, Mr. Lee has been an independent consultant and the owner of JL Innovative Transformations LLC, an executive
8-K
EX-99.1
GTHX
G1 Therapeutics Inc
12 Feb 24
Other Events
4:19pm
small cell lung cancer. G1’s goal is to provide innovative therapeutic advances for people living with cancer. G1 is based in Research Triangle Park
8-K
EX-99.1
9sye4l7w0v
28 Jun 22
G1 Therapeutics Announces Addition of Jacks Lee to Board of Directors
4:58pm
8-K
EX-99.1
d8rx3p9l
4 Aug 21
G1 Therapeutics Provides Second Quarter 2021 Financial Results and Operational Highlights
4:06pm
8-K
EX-99.1
jhw028m hji41a4
21 Jun 21
G1 Therapeutics Announces Addition of Alicia Secor to Board of Directors
4:06pm
8-K
EX-99.1
6wowjnx1ml s07p0
30 Mar 21
G1 Therapeutics’ COSELA™ (trilaciclib) Included in Two Updated National Comprehensive Cancer Network® (NCCN) Clinical Practice Guidelines in Oncology
12:00am
8-K
EX-99.1
k83odigxj1xi1
24 Feb 21
G1 Therapeutics Provides Fourth Quarter and Full Year 2020 Financial Results
4:08pm
8-K
EX-99.1
ajttgs0b65 fz254mq
30 Sep 20
G1 Therapeutics Announces Chief Executive Officer Succession Plan
4:08pm
8-K
EX-99.1
fg7tvziv4z7 15
5 Aug 20
G1 Therapeutics Provides Second Quarter 2020 Corporate and Financial Update
4:05pm
8-K
EX-99.1
y1bjdymj osc
30 Jun 20
G1 Therapeutics and Boehringer Ingelheim AnnounceCo-Promotion Agreement for Trilaciclib in Small Cell Lung Cancer in the United States and Puerto Rico
4:17pm
8-K
EX-99.1
expkrlp1 yco78
2 Jun 20
G1 Therapeutics Announces Flexible Credit Financing for Up to $100 Million with Hercules Capital
6:08am
8-K
EX-99.1
nkt6yol6w yi04qzvc0a
13 Mar 20
G1 Therapeutics Announces Appointment of New Board Member and Chief Commercial Officer
4:06pm
8-K
EX-99.1
9zk8a3va1 di
26 Feb 20
G1 Therapeutics Provides Fourth Quarter and Full-Year 2019 Corporate and Financial Update
4:05pm
8-K
EX-99.1
v0t4h8doewcdgebwjzxo
5 Nov 19
G1 Therapeutics Provides Third Quarter 2019 Corporate and Financial Update
4:07pm
8-K
EX-99.1
77u ch8uduo553
1 Oct 19
Other Events
5:29pm
8-K
EX-99.2
df93iqt
1 Oct 19
Other Events
5:29pm